Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
Eva Hoster(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Michael Unterhalt, Stephan Stilgenbauer(Universität Ulm), Vincent Ribrag(Institut Gustave Roussy), Catherine Thiéblemont(Université Paris Cité), Francesco Di Raimondo(University of Catania), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), Martin Dreyling(LMU Klinikum), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Michał Szymczyk(The Maria Sklodowska-Curie National Research Institute of Oncology), Olivier Hermine(Centre National de la Recherche Scientifique), Michael Hallek(Integrated Oncology (United States)), Marek Trněný(Charles University), Christian H. Geisler(Copenhagen University Hospital), Achiel Van Hoof(AZ Sint-Jan), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Jeanette K. Doorduijn(Erasmus MC Cancer Institute), Christiane Pott(University Hospital Schleswig-Holstein), Roswitha Forstpointner(LMU Klinikum)
Cited by 164
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k